The FormPrep system will change the way formulation development is done, allowing our customers to bring drugs to market faster with more robust formulations.
SUNNYVALE, Calif. (PRWEB) January 14, 2016
Freeslate, Inc., the leading provider of high throughput research solutions for biopharmaceutical development, today announced the introduction of the FormPrep system. Designed for scientists, Freeslate’s FormPrep automates biologics formulation preparation, buffer exchange, and sample concentration in one simple, easy-to-use system. FormPrep’s ability to prepare multiple formulations at high concentrations at a small scale allows scientists to evaluate high protein concentrations earlier in development. FormPrep’s automated workflow can also increase the repeatability and reproducibility of formulation preparation across projects, departments, and campaigns.
Buffer preparation, exchange, and sample concentration for a formulation screen can take 2-4 days of a scientist’s time for even the simplest screens. While many labs have developed strategies to streamline formulation development, it’s still relatively manual and requires significant resources which can limit the number of formulations evaluated. Freeslate has eliminated this bottleneck with the FormPrep system which enables scientists to easily, rapidly, and automatically generate up to 12 different protein formulations at the 0.5 mL to 8 mL scale every day with minimal hands-on time.
“We are committed to providing powerfully simple solutions for the rapid development of formulations for stable biologics,” said John S. Senaldi, President and CEO of Freeslate. “The FormPrep system will change the way formulation development is done, allowing our customers to bring drugs to market faster with more robust formulations.”
FormPrep is designed to work as a standalone system but can also be paired with Freeslate’s Lab Execution and Analysis (LEA) software suite. LEA allows scientists to collect all formulation information and analytical results into a single database for easy reporting and analysis. LEA also allows scientists to track and link all analytics and stress conditions back to the original formulation and share it across their organizations.
Freeslate is a privately held company providing laboratory automation products that dramatically improve the productivity and innovation of drug development organizations. For more than a decade, Freeslate has been working with customers to automate complex chemical research processes. Our resulting product line includes solutions for protein and vaccine drug formulation development, small molecule solubility, and polymorph screening and process chemistry. We start with a scientific understanding of our customer’s bottlenecks and utilize our robust and proprietary automation platforms and integrated Lab Execution and Analysis (LEA) software suite to deliver solutions that make a difference. The company is headquartered in Sunnyvale, California, with direct sales and service in North America, Europe, and Asia. For more information, visit http://www.freeslate.com.